gr 144053 has been researched along with Cerebral Infarction, Middle Cerebral Artery in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, J; Fernández, JÁ; Griffin, JH; Lamb, JA; Lei, IF; Leung, J; Lyden, PD; Pereira, BR; Rajput, PS | 1 |
1 other study(ies) available for gr 144053 and Cerebral Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
Neuroprotection and vasculoprotection using genetically targeted protease-ligands.
Topics: Animals; Anticoagulants; Brain; Brain Ischemia; Infarction, Middle Cerebral Artery; Ligands; Male; Neurons; Neuroprotection; Neuroprotective Agents; Piperazines; Piperidines; Protein C; Rats; Rats, Sprague-Dawley; Receptor, PAR-1; Receptors, Proteinase-Activated; Stroke; Thrombin | 2019 |